Here, we have investigated whether these phosphorylation sites are crucial to determining seeding efficiency of AD (AD-tau) or PSP (PSP-tau) brain derived tau seeds, using HEK 293 T cells expressing 0N/4R P301L tau as seeding recipients. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.